Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adverum Biotechnologies

2.93
-0.0500-1.68%
Post-market: 2.930.00000.00%16:05 EDT
Volume:307.56K
Turnover:885.02K
Market Cap:61.21M
PE:-0.44
High:3.01
Open:3.01
Low:2.75
Close:2.98
Loading ...

Adverum Biotechnologies Is Maintained at Buy by Chardan Capital

Dow Jones
·
17 Apr

RBC Cuts Price Target on Adverum Biotechnologies to $5 From $10, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
16 Apr

Adverum Biotechnologies Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Apr

RBC Capital Keeps Their Hold Rating on Adverum Biotechnologies (ADVM)

TIPRANKS
·
16 Apr

TD Cowen Reaffirms Their Buy Rating on Adverum Biotechnologies (ADVM)

TIPRANKS
·
16 Apr

Adverum Biotechnologies Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
15 Apr

Adverum Biotechnologies: Q4 Earnings Snapshot

Associated Press Finance
·
15 Apr

Adverum Biotechnologies Q4 EPS $(1.96) Misses $(1.38) Estimate

Benzinga
·
15 Apr

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones

THOMSON REUTERS
·
15 Apr

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones

GlobeNewswire
·
15 Apr

North American Morning Briefing: China Raises Tariffs on U.S. in Latest Salvo

Dow Jones
·
11 Apr

ADVISORY-Alert on Adverum Biotechnologies from press release by law firm withdrawn

Reuters
·
08 Apr

Investor Alert: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - Advm

THOMSON REUTERS
·
08 Apr

U.S. RESEARCH ROUNDUP- BlackRock, Morgan Stanley, ServiceNow

Reuters
·
08 Apr

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Apr

North American Morning Briefing: Stock Futures Fall, Bonds Rally as Investors Negotiate Market Turmoil

Dow Jones
·
04 Apr

Major Shareholder Makes Bold Move in Adverum Biotechnologies!

TIPRANKS
·
03 Apr

Adverum Biotechnologies Inc expected to post a loss of $1.36 a share - Earnings Preview

Reuters
·
02 Apr

BRIEF-Adverum Biotechnologies Inc - Some Prior Financial Statements Should No Longer Be Relied Upon - SEC Filing

Reuters
·
01 Apr

Adverum Biotechnologies Inc - Some Prior Financial Statements Should No Longer Be Relied Upon - SEC Filing

THOMSON REUTERS
·
01 Apr